Table 1.
a | b | c | d | e | f | g | h | i | j | |
---|---|---|---|---|---|---|---|---|---|---|
Early stage apoptotic rate (%) | 1.2 | 2.7 | 4.1 | 1.5 | 49.2 | 15.1 | 74.6 | 75.3 | 82.2 | 84.9 |
Late stage apoptotic rate (%) | 0 | 0 | 0 | 0 | 1.8 | 0.2 | 0.9 | 1.0 | 1.1 | 1.4 |
Total apoptotic rate (%) | 1.2 | 2.7 | 4.1 | 1.5 | 51.0 | 15.3 | 75.5 | 76.3 | 83.3 | 86.3 |
Notes: Cell apoptosis groups: a) blank, b) SWCNTs-HA, c) SWCNTs-HA/laser, d) Gd, e) DOX, f) Gd/SWCNTs-HA-DOX, g) SWCNT-HA-ss-DOX, h) Gd/SWCNTs-HA-ss-DOX, i) SWCNT-HA-ss-DOX/laser, j) Gd/SWCNTs-HA-ss-DOX/laser.
Abbreviations: DOX, doxorubicin; Gd, gadolinium; HA, hyaluronic acid; SWCNTs, single-walled carbon nanotubes; SWCNTs-HA, HA-modified SWCNTs.